Hepatic encephalopathy: Clinical aspects and pathogenesis;Hepatische enzephalopathie: Klinik und pathogenese

Deutsche Medizinische Wochenschrift

Volumn 129, Issue SUPPL. 2, 2004, Pages

  Haussinger D ^a,b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BENZODIAZEPINE; CYTOKINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ASTROCYTE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY; SHORT SURVEY; SIGNAL TRANSDUCTION;

AMMONIA; BRAIN; DIAGNOSIS, DIFFERENTIAL; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; STATISTICS;

EID: 4644257673     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831375     Document Type: Short Survey

References (14)

1. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis 1996; 16: 23544
2. Ferenci P. Müller C. Chapter 26. Hepatic encephalopathy: treatment. BMJ Publishing group, London, In JWD McDonald, AK Bourroughs, BG Feagan (eds): Evidence based gastroenterology and hepatology. 1999
3. Häussinger D, Kircheis G, Fischer R, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and chronic low grade cerebral edema? J Hepatol 2000; 32: 1035-1038
4. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopic studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475-1480
5. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency and quantification of low grade hepatic encephalopathy. Hepatology 2002; 35: 357-366
6. Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liv Dis 1996; 16: 245-253
7. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-479
8. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J. Magnetization tranfer ratio values and proton MR spectroscopy of normal appearing cerebral white matter in patients with liver cirrhosis. Am J Neuroradiol 2001; 22: 1137-1142
9. Schliess F, Görg B, Fischer R, Desjardins P, Bidmon HJ, Herrmann A, Butterworth RF, Zilles K, Häussinger D. Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J 2002; 16: 739-741
10. Schomerus H, Schreiegg J. Prevalence of latent portosystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 1993; 31: 231-234
11. Timmermann L, Gross J, Kircheis G, Dirks M, Schmitz F, Häussinger D, Schnitzler A. Cortical origin of postural minimal asterixis in hepatic encephalopathy. Neurology 2002; 58: 296-298
12. Watanabe A, Kuwabara Y, Okita H, Kato A. Computer-assisted quantitative neuropsychological tests for early detection of subclinical hepatic encephalopathy in patients with liver cirrhosis. Res Commun Biol Psychology Psychiatry 1997; 22: 25-38
13. Wettstein M, Häussinger D. Hepatische Enzephalopathie - Therapie. Dtsch Med Wochenschr 2003; 128: 2658-2661
14. Wettstein M, Kircheis G, Häussinger D. Hepatische Enzephalopathie - Diagnostik. Dtsch Med Wochenschr 2003; 128: 2654-2657